Clinical Trials Directory

Trials / Terminated

TerminatedNCT05234164

HORIZON Prospective Clinical Investigation

HORIZON. Clinical Investigation of the Qmedics EXIST NiTi Stent Type FLEX & PULL in Adults With Peripheral Artery Disease (PAD)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Qmedics AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this clinical investigation is to demonstrate and provide long term clinical data on safety and performance of the Exist 6F NiTi stent system type FLEX \& PULL in a prospective investigation for the treatment of adult patients with de novo or re-stenotic symptomatic atherosclerotic lesions in Peripheral Artery Disease (PAD) requiring treatment of the Superficial Femoral Artery (SFA) or Proximal Popliteal Artery (P1 segment).

Detailed description

This is a multicenter, prospective study with clinical and radiographic follow-up for 24 months months post-procedure. Approximately two hundred thirty subjects will be enrolled (115 subjects will receive the FLEX type and 115 subjects the PULL type) in several centers, minimum 10 patients per investigational center. All patients will be evaluated at 30 days and 6-, 12- and 24-months post-index procedure.

Conditions

Interventions

TypeNameDescription
DEVICEEXIST 6F NiTi Stent System FLEXSubjects requiring treatment of the P1 segment of the proximal popliteal artery will be treated with the Exist 6F NiTi Stent FLEX type. Subjects requiring treatment of the SFA will undergo an additional calcification review based on the Fanelli classification. Subjects graded with Fanelli 1 or 2 will be treated with the Exist 6F NiTi Stent FLEX type.
DEVICEEXIST 6F NiTi Stent System PULLSubjects requiring treatment of the SFA will undergo a calcification review based on the Fanelli classification. Subjects graded with Fanelli grade 3 and 4 will be treated with the Exist 6F NiTi Stent PULL type.

Timeline

Start date
2021-12-15
Primary completion
2023-11-17
Completion
2023-11-17
First posted
2022-02-10
Last updated
2024-02-14

Locations

2 sites across 2 countries: Italy, Poland

Source: ClinicalTrials.gov record NCT05234164. Inclusion in this directory is not an endorsement.